NovoCure Ltd (NVCR)
17.09
+0.23
(+1.36%)
USD |
NASDAQ |
Nov 21, 16:00
17.11
+0.02
(+0.12%)
After-Hours: 20:00
NovoCure Profit Margin (Quarterly): -19.71% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -19.71% |
| June 30, 2024 | -22.20% |
| March 31, 2024 | -27.98% |
| December 31, 2023 | -35.19% |
| September 30, 2023 | -38.87% |
| June 30, 2023 | -45.55% |
| March 31, 2023 | -43.43% |
| December 31, 2022 | -29.05% |
| September 30, 2022 | -20.29% |
| June 30, 2022 | -17.04% |
| March 31, 2022 | -3.38% |
| December 31, 2021 | -19.86% |
| September 30, 2021 | -9.82% |
| June 30, 2021 | -10.97% |
| March 31, 2021 | -3.06% |
| December 31, 2020 | 3.42% |
| September 30, 2020 | 7.00% |
| June 30, 2020 | 1.43% |
| March 31, 2020 | 3.88% |
| December 31, 2019 | 4.29% |
| September 30, 2019 | 2.10% |
| Date | Value |
|---|---|
| June 30, 2019 | -1.46% |
| March 31, 2019 | -16.57% |
| December 31, 2018 | -22.43% |
| September 30, 2018 | -18.06% |
| June 30, 2018 | -25.21% |
| March 31, 2018 | -39.76% |
| December 31, 2017 | -20.40% |
| September 30, 2017 | -22.95% |
| June 30, 2017 | -55.18% |
| March 31, 2017 | -51.73% |
| December 31, 2016 | -73.30% |
| September 30, 2016 | -155.2% |
| June 30, 2016 | -226.6% |
| March 31, 2016 | -271.5% |
| December 31, 2015 | -265.9% |
| September 30, 2015 | -290.7% |
| June 30, 2015 | -448.7% |
| March 31, 2015 | -446.9% |
| December 31, 2014 | -602.9% |
| September 30, 2014 | -418.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-45.55%
Minimum
Jun 2023
7.00%
Maximum
Sep 2020
-16.32%
Average
-18.38%
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 15.48% |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | -18.58% |
| Xtant Medical Holdings Inc | -17.98% |
| Catheter Precision Inc | -4.29K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.74% |
| Return on Assets | -12.81% |
| Return on Invested Capital | -15.43% |
| Gross Profit Margin (Quarterly) | 77.19% |
| Operating Margin (Quarterly) | -20.69% |
| Return on Net Operating Assets | -61.28% |